TT&A, A&O Shearman advise broker on sale of ₹250 crore Anthem Biosciences shares by Portsmouth Tech
Portsmouth Technologies, LLC has made a secondary sale of 3,000,000 equity shares of Anthem Biosciences Limited, amounting to approximately ₹250 crore, on the screen-based trading platform of the BSE and the NSE. TT&A advised J.P. Morgan India Private Limited , the broker on this share sale. The transaction team consisted of Abhinav Kumar (Partner) and Indira Satish (Senior Associate).
Sources
Open in the live tracker →Related deals
- Morrison Foerster, Khaitan & Co advises Autodesk on acquisition of select tech assets, intellectual property from BIMDeX28 Oct 2026
- Trilegal acts on Fusion CX ₹702 crore IPO26 Oct 2026 · ₹702 cr
- Fox & Mandal, Shardul Amarchand Mangaldas act on Canada-based Infotech acquiring Zluri26 Oct 2026
- HCL Technologies Limited: General Updates26 Oct 2026
- Newgen Software Technologies Limited: Amalgamation/Merger23 Oct 2026
- Slaughter and May, Eversheds Sutherland, Khaitan & Co act on Brahma AI $150 million fundraise22 Oct 2026 · $150 mn